Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Особенности проведения программ вспомогательных репродуктивных технологий у женщин старше 40 лет за счет средств обязательного медицинского страхования
________________________________________________
Kuleshova D.A., Melehova N.Yu., Gustovarova T.A. et al. Features of the art programs funded by the СHI in women over 40 years of age. Gynecology. 2016; 18 (5): 50–52.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: вспомогательные репродуктивные технологии, возраст, обязательное медицинское страхование.
________________________________________________
Purpose of the study is assessment of the effectiveness of the ART programs funded by the Compulsory Health Insurance Fund among patients older than 40 years of age.
80 ART programs at the expense of the mandatory health insurance funds (40 patients at the age of 40 and older, 40 patients younger than 40 years) have been analyzed.
We have analyzed the data of the anamnesis, clinical and gynecological examinations, hormonal status, ultrasound scans, parameters of folliculogenesis in stimulation protocol, number and quality of the oocytes and embryos. There’s a tendency of age-related decrease in number and quality of the embryos. The effectiveness of the ART programs in women of this age group is not high (20%), which requires an expansion of using the donor oocytes’cycles.
Key words: assisted reproductive technology, age, compulsory health insurance.
/d_registr_otchet/pdf
2. Szafarowska М, Jerzak М. Ovarian aging and infertility. Ginekol Pol 2013; 84 (4): 298–304.
3. Hassold T, Hunt P. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew. Curr Opin Pediatr 2009; 21 (6): 703–8.
4. Jacobsson B et al. Advance maternal age and adverse perinatal outcome. Obstet Gynecol 2004; 104: 727–33.
5. Приказ Минздрава России от 10.12.2013 №916н «О перечне видов высокотехнологичной медицинской помощи». / Prikaz Minzdrava Rossii ot 10.12.2013 №916n «O perechne vidov vysokotekhnologichnoi meditsinskoi pomoshchi». [in Russian]
6. Khoufache K, Michaud N, Harir N et al. Anomalies in the inflammatory response in endometriosis and possible consequences: a review. Minerva Endocrinol 2012; 37 (1): 75–92.
________________________________________________
1. Материалы http://www.rahr.ru/registr_otchet.php1http://www.rahr.ru/
/d_registr_otchet/pdf
2. Szafarowska М, Jerzak М. Ovarian aging and infertility. Ginekol Pol 2013; 84 (4): 298–304.
3. Hassold T, Hunt P. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew. Curr Opin Pediatr 2009; 21 (6): 703–8.
4. Jacobsson B et al. Advance maternal age and adverse perinatal outcome. Obstet Gynecol 2004; 104: 727–33.
5. Prikaz Minzdrava Rossii ot 10.12.2013 №916n «O perechne vidov vysokotekhnologichnoi meditsinskoi pomoshchi». [in Russian]
6. Khoufache K, Michaud N, Harir N et al. Anomalies in the inflammatory response in endometriosis and possible consequences: a review. Minerva Endocrinol 2012; 37 (1): 75–92.
1. ФГБОУ ВО Смоленский государственный медицинский университет Минздрава России. 214019, Россия, Смоленск, ул. Крупской, д. 28;
2. ООО Медицинский центр «Гинея». 214000, Россия, Смоленск, ул. Пржевальского, д. 6/25
*darja-gruzdova@rambler.ru
________________________________________________
D.A.Kuleshova*1, 2, N.Yu.Melehova2, T.A.Gustovarova1, A.N.Ivanyan1, A.L.Chernyakova2, C.B.Krukovsky1
1. Smolensk State Medical University of the Ministry of Health of the Russian Federation. 214019, Russian Federation, Smolensk, ul. Krupskoj, d. 28;
2. LLC Medical Center «Guinea». 214000, Russian Federation, Smolensk, ul. Przhevalskogo, d. 6/25
*darja-gruzdova@rambler.ru